Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer
暂无分享,去创建一个
I. Ellis | A. Green | E. Rakha | Madeleine L Craze | Omar J Mohammed | Rokaya El-Ansari | L. Alfarsi | Brendah K Masisi
[1] Xin Zhao,et al. Structure of the human LAT1–4F2hc heteromeric amino acid transporter complex , 2019, Nature.
[2] A. Gavin,et al. Cell metabolism regulates integrin mechanosensing via an SLC3A2-dependent sphingolipid biosynthesis pathway , 2018, Nature Communications.
[3] M. Hediger,et al. Amino acid transporters revisited: New views in health and disease. , 2018, Trends in biochemical sciences.
[4] A. Green,et al. Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancer , 2018, Histopathology.
[5] W. Sauerbrei,et al. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration , 2018, Journal of the National Cancer Institute.
[6] I. Ellis,et al. The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours , 2018, Breast Cancer Research.
[7] I. Ellis,et al. The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes , 2018, British Journal of Cancer.
[8] I. Ellis,et al. Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations , 2018, Histopathology.
[9] K. Guan,et al. Differential regulation of mTORC1 by leucine and glutamine , 2015, Science.
[10] Tomoya Mizuno,et al. Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma , 2013, BMC Cancer.
[11] M. Malumbres,et al. HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5. , 2012, Molecular cell.
[12] F. Markowetz,et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.
[13] T. Tamiya,et al. Relation of LAT1/4F2hc expression with pathological grade, proliferation and angiogenesis in human gliomas , 2012, BMC Clinical Pathology.
[14] J. Horiguchi,et al. Correlation of L‐type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis , 2012, Cancer science.
[15] Jeffrey P. MacKeigan,et al. Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy , 2009, Cell.
[16] Y. Kanai,et al. L‐type amino‐acid transporter 1 as a novel biomarker for high‐grade malignancy in prostate cancer , 2009, Pathology international.
[17] N. Sunaga,et al. Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer , 2008, British Journal of Cancer.
[18] G. Prager,et al. CD98hc (SLC3A2) Interaction with the Integrin β Subunit Cytoplasmic Domain Mediates Adhesive Signaling* , 2007, Journal of Biological Chemistry.
[19] Gavin D. Grant,et al. Common markers of proliferation , 2006, Nature Reviews Cancer.
[20] Y. Kanai,et al. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. , 2001, Biochimica et biophysica acta.
[21] S. Kimball,et al. Regulation of translation initiation by amino acids in eukaryotic cells. , 2001, Progress in molecular and subcellular biology.
[22] T. Masuko,et al. Transformation of BALB3T3 cells caused by over‐expression of rat CD98 heavy chain (HC) requires its association with light chain: Mis‐sense mutation in a cysteine residue of CD98HC eliminates its transforming activity , 2000, International journal of cancer.
[23] K. Tomita,et al. 4F2 (CD98) Heavy Chain Is Associated Covalently with an Amino Acid Transporter and Controls Intracellular Trafficking and Membrane Topology of 4F2 Heterodimer* , 1999, The Journal of Biological Chemistry.
[24] C. Shoemaker,et al. Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family , 1998, Nature.